Krystal Biotech Inc
F:4KB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Krystal Biotech Inc
F:4KB
|
US |
|
Celestica Inc
F:CTW0
|
CA |
|
A
|
AXA SA
LSE:0HAR
|
FR |
|
C
|
CH Robinson Worldwide Inc
F:CH1A
|
US |
|
S
|
Starwood Property Trust Inc
F:VSP
|
US |
|
I
|
Industrial and Commercial Bank of China Ltd
DUS:ICK
|
CN |
|
Gerdau SA
F:GDUB
|
BR |
|
B
|
Budweiser Brewing Company APAC Ltd
OTC:BDWBF
|
HK |
|
A
|
AeroVironment Inc
F:JPX
|
US |
|
A
|
Alcoa Corp
F:185
|
US |
|
S
|
Subsea 7 SA
XBER:SOC
|
UK |
|
SPX Corp
NYSE:SPXC
|
US |
|
Olam Group Ltd
SGX:VC2
|
SG |
Wall St Price Targets
4KB Price Targets Summary
Krystal Biotech Inc
According to Wall Street analysts, the average 1-year price target for 4KB is 183.93 EUR with a low forecast of 124.43 EUR and a high forecast of 228.63 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4KB's stock price target?
Price Target
183.93
EUR
According to Wall Street analysts, the average 1-year price target for 4KB is 183.93 EUR with a low forecast of 124.43 EUR and a high forecast of 228.63 EUR.
What is the Revenue forecast for Krystal Biotech Inc?
Projected CAGR
17%
The compound annual growth rate for Revenue over the next 8 years is 17%.
What is the Operating Income forecast for Krystal Biotech Inc?
Projected CAGR
26%
The compound annual growth rate for Operating Income over the next 8 years is 26%.
What is the Net Income forecast for Krystal Biotech Inc?
Projected CAGR
16%
The compound annual growth rate for Net Income over the next 7 years is 16%.
